![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Hopefully this one will gain more traction
Apple
AAPL
Cisco
CSCO
Disney
DIS
4
Qualcomm
QCOM
5
Taiwan Semiconductor
TSM
US Stock MarketDetailed Quotes
CERO CERo Therapeutics
- 0.730
- -0.021-2.80%
Close Mar 31 16:00 ET
- 0.700
- -0.030-4.11%
Pre 05:07 ET
2.21MMarket Cap0.00P/E (TTM)
0.798High0.670Low6.51MVolume0.730Open0.751Pre Close5.47MTurnover265.31%Turnover Ratio0.00P/E (Static)3.03MShares213.00052wk High-0.30P/B1.79MFloat Cap0.66052wk Low--Dividend TTM2.45MShs Float1280.000Historical High--Div YieldTTM17.03%Amplitude0.660Historical Low0.840Avg Price1Lot Size
CERo Therapeutics Stock Forum
Sign in to post a comment
$CERo Therapeutics (CERO.US)$ This has been doing really well today in spite of the current climate, my only wish is that I had bought in heavier this morning lol
1
$CERo Therapeutics (CERO.US)$
Groundbreaking CAR-T Cancer Therapy Advances: FDA Greenlights Dual-Action Trial
Groundbreaking CAR-T Cancer Therapy Advances: FDA Greenlights Dual-Action Trial
1
$CERo Therapeutics (CERO.US)$
Cero Therapeutics Holdings, Inc. Receives FDA Clearance of Second Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Lead Compound CER-1236 in Solid Tumors
Cero Therapeutics Holdings, Inc. Receives FDA Clearance of Second Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Lead Compound CER-1236 in Solid Tumors
1
$CERo Therapeutics (CERO.US)$ Reuters· 1 min ago
Cero Therapeutics Holdings, Inc. Receives FDA Clearance of Second Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Lead Compound CER-1236 in Solid Tumors
Cero Therapeutics Holdings, Inc. Receives FDA Clearance of Second Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Lead Compound CER-1236 in Solid Tumors
$CERo Therapeutics (CERO.US)$
CERo Therapeutics Holdings, Inc. Receives FDA Clearance of Second Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Lead Compound CER-1236 in Solid Tumors
Monday, 31st March at 8:15 am
SOUTH SAN FRANCISCO, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (NASDAQ: CERO) ("CERo" or the "Company") an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that empl...
CERo Therapeutics Holdings, Inc. Receives FDA Clearance of Second Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Lead Compound CER-1236 in Solid Tumors
Monday, 31st March at 8:15 am
SOUTH SAN FRANCISCO, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (NASDAQ: CERO) ("CERo" or the "Company") an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that empl...
2
5
$CERo Therapeutics (CERO.US)$ died so fast lol
$CERo Therapeutics (CERO.US)$ can buy now ??
1
$CERo Therapeutics (CERO.US)$ careful with this scam will fall usual after posting good news🙏🙏🙏
2
$CERo Therapeutics (CERO.US)$ hello 1.10
1
$CERo Therapeutics (CERO.US)$
CERo Therapeutics Holdings, Inc. Poised to Initiate Enrollment of Phase 1 Trial of CER-1236 in AML Following Positive FDA Review of Manufacturing
Thursday, 27th March at 8:15 am
Company reports acceptance of an abstract at the 2025 American Society of Clinical Oncology (ASCO) conference; Continues to be on track to dose first patient in first half of 2025
SOUTH SAN FRANSCISCO, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (NASDAQ: C...
CERo Therapeutics Holdings, Inc. Poised to Initiate Enrollment of Phase 1 Trial of CER-1236 in AML Following Positive FDA Review of Manufacturing
Thursday, 27th March at 8:15 am
Company reports acceptance of an abstract at the 2025 American Society of Clinical Oncology (ASCO) conference; Continues to be on track to dose first patient in first half of 2025
SOUTH SAN FRANSCISCO, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (NASDAQ: C...
No comment yet
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
Barbarian Z : What is good?